SOP Guide for Pharma

SOP for Process Validation of Sustained-Release Capsules

SOP for Process Validation of Sustained-Release Capsules

Standard Operating Procedure for Validating Sustained-Release Capsule Manufacturing Process

1) Purpose

The purpose of this Standard Operating Procedure (SOP) is to outline the procedures for the process validation of sustained-release capsules. This SOP ensures that the manufacturing process consistently produces capsules that meet the required quality specifications and maintain the intended release profile. By following this SOP, the company ensures that sustained-release capsules are safe, effective, and manufactured in compliance with regulatory standards.

2) Scope

This SOP is applicable to the manufacturing of all sustained-release capsules produced in the facility. It covers the process validation activities for new sustained-release formulations, as well as those undergoing significant changes in the manufacturing process. This SOP is intended for use by quality assurance (QA), production teams, and technical personnel involved in the formulation, manufacturing, and validation of sustained-release capsules.

3) Responsibilities

Operators: Responsible for performing process validation tasks according to the approved protocol.
Quality Assurance (QA): Ensures that the process validation is carried out in compliance with this SOP and meets regulatory requirements. QA is responsible for reviewing and approving the validation reports.
Production Supervisors: Oversee the validation process and ensure that all activities are performed according to the

approved protocol and procedures.
Validation Team: Responsible for creating the validation protocol, executing the validation runs, and analyzing the results.
Maintenance Personnel: Ensures that all equipment used in the manufacturing process is properly calibrated and maintained.

4) Procedure

The following steps should be followed for the process validation of sustained-release capsule manufacturing:

1. Preparation for Validation:
1.1 Review batch records to identify critical process parameters (CPPs) for each stage of the sustained-release capsule manufacturing process.
1.2 Develop a process validation protocol that includes the objectives, scope, equipment, process flow, and involved personnel.
1.3 Ensure that all equipment, including capsule filling machines, capsule coating machines, and dissolution testing apparatus, are calibrated and operational.

2. Validation Protocol:
2.1 Protocol Design: The validation protocol should be based on the formulation of the sustained-release capsules and the specific manufacturing process.
2.2 Defining Acceptance Criteria: Establish acceptance criteria for critical parameters such as capsule weight, content uniformity, release rate, and coating integrity.
2.3 Risk Assessment: Conduct a risk assessment to identify critical quality attributes (CQAs) and corresponding critical process parameters (CPPs), ensuring that potential risks to product quality are identified and mitigated.

3. Execution of Validation:
3.1 Mixing: Validate the mixing process to ensure the uniform distribution of active ingredients and excipients. Control the mixing time, speed, and temperature to achieve homogeneity.
3.2 Granulation (if applicable): Validate the granulation process by ensuring the proper size and uniformity of granules for sustained-release formulations.
3.3 Capsule Filling: Validate the capsule filling process, ensuring that the correct weight of the active ingredient and excipients are filled into each capsule.
3.4 Coating: If applicable, validate the coating process to ensure the proper coating thickness and uniformity, which is essential for controlling the drug release rate.
3.5 Release Testing: Perform in vitro dissolution testing to validate the sustained-release profile. Ensure that the capsules release the active ingredient over the intended time period in compliance with the drug release specifications.

4. Documentation and Reporting:
4.1 Record all data during the validation process, including batch records, equipment logs, process parameters, and testing results.
4.2 Ensure that all forms, reports, and certificates are completed and signed by the responsible personnel.
4.3 Perform statistical analysis on the collected data to assess process capability and confirm that the process meets the acceptance criteria.
4.4 Prepare a final validation report summarizing the results, including any deviations from the acceptance criteria and corrective actions taken, if necessary.

5. Revalidation:
5.1 Revalidate the process if there are any changes to the formulation, raw materials, equipment, or critical process parameters.
5.2 Conduct periodic revalidation to ensure continued compliance with regulatory requirements and consistent product quality.

5) Abbreviations

  • QA: Quality Assurance
  • CPP: Critical Process Parameter
  • CQA: Critical Quality Attribute
  • SOP: Standard Operating Procedure

6) Documents

  • Process Validation Protocol
  • Batch Production Records
  • Equipment Calibration Logs
  • Process Validation Reports
  • Raw Material Certificates of Analysis
  • Statistical Analysis Data

7) Reference

  • International Council for Harmonisation (ICH) Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
  • FDA Guidance for Industry: Process Validation
  • ISO 9001: Quality Management Systems – Requirements

8) SOP Version

Version 1.0 – Effective Date: DD/MM/YYYY

Annexure

Template 1: Mixing Process Record

Date Time Operator Initials Mixing Duration Remarks
DD/MM/YYYY HH:MM Operator Name Duration in minutes Process completed as per SOP
         

Template 2: Capsule Filling Record

Batch No. Filling Date Capsule Weight Operator Initials Supervisor Signature
Batch Number DD/MM/YYYY Weight in mg Operator Name Supervisor Name
         

Template 3: Coating Process Record

Batch No. Coating Date Coating Thickness Coating Uniformity Operator Initials Supervisor Signature
Batch Number DD/MM/YYYY Thickness in microns Pass/Fail Operator Name Supervisor Name
           

Template 4: Dissolution Testing Record

Batch No. Test Date Time Point Cumulative Release (%) Operator Initials
Batch Number DD/MM/YYYY Time (minutes) Release in % Operator Name
         

Template 5: Raw Material Certificate of Analysis

Material ID Supplier Batch No. Test Result Approved By
Material Number Supplier Name Batch Number Test Result QC Name
         

Template 6: Statistical Analysis Data

Sample ID Test Type Mean Standard Deviation Result
Sample Number Test Name Mean Value Standard Deviation Pass/Fail
         
Exit mobile version